{"id":"https://openalex.org/W2175289780","doi":"https://doi.org/10.1089/108497802760363150","title":"Pharmacokinetic Characteristics and Biodistribution of Radioiodinated Chimeric TNT-1, -2, and -3 Monoclonal Antibodies After Chemical Modification with Biotin","display_name":"Pharmacokinetic Characteristics and Biodistribution of Radioiodinated Chimeric TNT-1, -2, and -3 Monoclonal Antibodies After Chemical Modification with Biotin","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W2175289780","doi":"https://doi.org/10.1089/108497802760363150","mag":"2175289780","pmid":"https://pubmed.ncbi.nlm.nih.gov/12396700"},"language":"en","primary_location":{"id":"doi:10.1089/108497802760363150","doi":"https://doi.org/10.1089/108497802760363150","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108497802760363150","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021299258","display_name":"Leslie A. Khawli","orcid":"https://orcid.org/0000-0002-7346-2818","observed_orcids":["https://orcid.org/0000-0002-7346-2818"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie A. Khawli","raw_affiliation_strings":["Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041669747","display_name":"Myra M. Mizokami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myra M. Mizokami","raw_affiliation_strings":["Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075403682","display_name":"Jahangir Sharifi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jahangir Sharifi","raw_affiliation_strings":["Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081373240","display_name":"Peisheng Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peisheng Hu","raw_affiliation_strings":["Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077143749","display_name":"Alan L. Epstein","orcid":"https://orcid.org/0000-0002-1834-7729","observed_orcids":["https://orcid.org/0000-0002-1834-7729"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan L. Epstein","raw_affiliation_strings":["Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1174212"],"apc_list":null,"apc_paid":null,"fwci":1.7144,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.84094911,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"17","issue":"4","first_page":"359","last_page":"370"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-monoclonal-antibody","display_name":"chimeric monoclonal antibody","score":0.9660000205039978},{"id":"https://openalex.org/keywords/biotinylated-antibodies","display_name":"biotinylated antibodies","score":0.7620000243186951},{"id":"https://openalex.org/keywords/radioiodinated-antibodies","display_name":"radioiodinated antibodies","score":0.7390000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9890000224113464},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.5419999957084656},{"id":"https://openalex.org/keywords/antibody-clearance","display_name":"antibody clearance","score":0.6420000195503235},{"id":"https://openalex.org/keywords/tumor-uptake","display_name":"tumor uptake","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.9667109251022339},{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.8112791776657104},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.8023999929428101},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.747921884059906},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6420259475708008},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6349015235900879},{"id":"https://openalex.org/C2778204606","wikidata":"https://www.wikidata.org/wiki/Q181354","display_name":"Biotin","level":2,"score":0.5893584489822388},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5272418856620789},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4192362129688263},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2786584496498108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25416460633277893},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20588308572769165},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17702645063400269},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10319522023200989}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019921","descriptor_name":"Biotinylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/108497802760363150","doi":"https://doi.org/10.1089/108497802760363150","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108497802760363150","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"pmid:12396700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12396700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biotherapy & radiopharmaceuticals","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.4300000071525574,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W45695722","https://openalex.org/W49117486","https://openalex.org/W332843415","https://openalex.org/W1716119428","https://openalex.org/W1736394754","https://openalex.org/W1775429285","https://openalex.org/W1824434699","https://openalex.org/W1906201429","https://openalex.org/W1964891080","https://openalex.org/W1964977681","https://openalex.org/W1971628265","https://openalex.org/W1973851728","https://openalex.org/W1982018874","https://openalex.org/W2000017737","https://openalex.org/W2005578281","https://openalex.org/W2007165747","https://openalex.org/W2027540110","https://openalex.org/W2035174039","https://openalex.org/W2044311605","https://openalex.org/W2044577630","https://openalex.org/W2054197767","https://openalex.org/W2055440368","https://openalex.org/W2098712880","https://openalex.org/W2118551545","https://openalex.org/W2186109763","https://openalex.org/W2285506432","https://openalex.org/W2415062893","https://openalex.org/W2416556662","https://openalex.org/W2469183393","https://openalex.org/W2516800439","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2000017737","https://openalex.org/W1971628265","https://openalex.org/W2416556662","https://openalex.org/W1979469202","https://openalex.org/W2149066612","https://openalex.org/W2118551545","https://openalex.org/W2000053426","https://openalex.org/W2100114198","https://openalex.org/W2368447244","https://openalex.org/W2074927777"],"abstract_inverted_index":{"To":[0,79],"improve":[1,71],"the":[2,18,30,58,65,72,105,162,169,172,185,194],"clinical":[3],"potential":[4,66],"of":[5,32,67,75,107,171,189,197],"monoclonal":[6],"antibodies":[7,191],"(MAbs),":[8],"new":[9],"methods":[10],"are":[11],"required":[12],"to":[13,35,53,70,131,143,178,193],"augment":[14],"antibody":[15,173],"uptake":[16,115,164],"in":[17,23,57,165],"tumor":[19,114],"while":[20],"minimizing":[21],"binding":[22,52],"normal":[24],"tissues.":[25],"Our":[26],"laboratory":[27],"has":[28],"pioneered":[29],"use":[31],"chemical":[33,68,175],"modification":[34,69,82,176],"accomplish":[36],"this":[37,159],"goal.":[38],"Using":[39],"three":[40],"chimeric":[41],"MAbs,":[42],"chTNT-1,":[43,119],"chTNT-2,":[44,122],"and":[45,93,97,123,138,187],"chTNT-3,":[46],"which":[47],"target":[48],"solid":[49,198],"tumors":[50],"by":[51,95],"common":[54],"antigens":[55],"found":[56,130],"central":[59],"necrotic":[60,195],"core,":[61],"we":[62],"now":[63],"demonstrate":[64],"pharmacokinetic":[73],"characteristics":[74],"these":[76],"unique":[77],"MAbs.":[78],"identify":[80],"optimal":[81,113],"conditions,":[83],"TNT":[84,190],"MAbs":[85,128],"were":[86,116,129],"reacted":[87],"with":[88],"biotin":[89,108],"at":[90],"various":[91],"ratios":[92],"tested":[94],"clearance":[96,136],"biodistribution":[98,101,140,155,188],"analyses.":[99],"The":[100],"results":[102,156],"revealed":[103],"that":[104,158],"numbers":[106],"molecules":[109],"per":[110],"MAb":[111,160],"yielding":[112],"3:1":[117],"for":[118,121,125,183],"5:1":[120],"8:1":[124],"chTNT-3.":[126],"Biotinylated":[127],"have":[132],"faster":[133],"whole":[134],"body":[135],"times":[137],"better":[139],"profiles":[141],"compared":[142],"unmodified":[144],"antibodies.":[145],"Although":[146],"chTNT-2":[147],"showed":[148],"only":[149],"a":[150,180],"modest":[151],"improvement":[152],"after":[153],"biotinylation,":[154],"indicated":[157],"had":[161],"highest":[163],"tumor.":[166],"By":[167],"reducing":[168],"charge":[170],"molecule,":[174],"appears":[177],"be":[179],"useful":[181],"method":[182],"improving":[184],"pharmacokinetics":[186],"directed":[192],"region":[196],"tumors.":[199]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}